Evidence map›Paper›PMID 42360802›Full record

ArticleeLife2026

Conformational variability of HIV-1 Env trimer and viral vulnerability.

Yiwei Cao, Wonpil Im

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Yiwei CaoDepartment of Biological Sciences, Lehigh University, Bethlehem, United States.ORCID https://orcid.org/0000-0002-4516-8689
Wonpil ImDepartment of Biological Sciences, Lehigh University, Bethlehem, United States.ORCID https://orcid.org/0000-0001-5642-6041

Funding

Development of Computational Tools and Their Applications to Various Biological SystemsR35GM153458 · NIGMS · LEHIGH UNIVERSITY · PI Wonpil Im · 2024 to 2026
$1.2M
NIGMS NIH HHS R35 GM153458NIH HHS R35-GM153458
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) is critical for viral fusion and entry into host cells and remains a primary target for vaccine and antiviral drug development. Advances in soluble gp140 trimer design have provided insight into the ectodomain structure and dynamics. While structural information is available for the membrane-proximal external region (MPER) and transmembrane domain (TMD), these regions remain comparatively understudied. Furthermore, high-resolution structural information for the cytoplasmic tail (CT), particularly within the context of the intact trimer, is limited and largely uncertain. Additionally, previous studies have typically treated the ectodomain and TMD as separate entities. To investigate the trimeric gp120-gp41 as a complete entity and its structural flexibility, we built a full-length model of the gp120-gp41 trimer that is fully glycosylated with N-linked glycans and embedded in a lipid bilayer, and performed all-atom molecular dynamics simulations. Our results show that the ectodomain maintains a rigid internal structure stable in the prefusion state, whereas the intrinsic flexibility of the MPER enables the ectodomain to adopt a range of tilted orientations, potentially enhancing spatial alignment for receptor engagement. The centrally positioned R696 residue in the TMD interacts with lipid headgroups, ions, and CT residues, resulting in conformational variability in the TMD and perturbations in the surrounding membrane that may facilitate the fusion process. Finally, we demonstrate how simulation trajectories can be leveraged to evaluate the accessibility of antibody epitopes across different regions of the protein.

Indexed as

HIV-1HIV Envelope Protein gp120HIV Envelope Protein gp41Protein MultimerizationHumansMolecular Dynamics SimulationProtein ConformationHIV Envelope Protein gp120HIV Envelope Protein gp41antibodyglycangp120–gp41HIV envelopemolecular biophysicsmolecular dynamics simulationstructural biologyviruses

Identifiers

PMID42360802
PMCPMC13309128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.